Vitrolife AB

VITR.ST · Health Technology · Biotechnology · SE

418 employees · vitrolife.com

About

Vitrolife AB is a Swedish biotech company specializing in the development and marketing of products for in vitro fertilization (IVF) and regenerative medicine. It was founded in 1994 and has over 390 employees worldwide. The company's main business is IVF, offering a wide range of essential products for IVF treatment such as culture media, devices for semen analysis and preparation, embryo transfer techniques, and products for biopsy examinations and cryopreservation. Vitrolife has a presence in 110 countries and has expanded its market to China where there is a high demand for fertility treatments. The company also offers medical equipment for regenerative treatments. Vitrolife is a leading player in the IVF industry known for its high product quality and innovation. It collaborates with universities and research institutions globally to improve IVF technology and success rates. The company places importance on sustainability and environmental protection, using 100% animal-free ingredients in their culture media and practicing recycling and waste reduction in their production facilities. In summary, Vitrolife offers a wide range of products for IVF and regenerative medicine, with a focus on supporting IVF treatments. The company is a leader in its industry and actively participates in research. It is committed to sustainability and environmental responsibility.

Annual results

Reported figures, SEK · revenue down 4.7% in 2025

YearRevenueNet incomeNet marginFree cash flow
20253.4B-5.0B-145.7%—
20243.6B513M14.2%—
20233.5B-3.9B-109.7%—
20223.2B394M12.2%—
20211.7B341M20.3%—

Dividends per share

2026 1.10 SEK2025 1.10 SEK2024 2.00 SEK2023 0.85 SEK2022 0.80 SEK

VITR.ST in MarketPulse

The live chart with RSI and moving averages, the price, news, signals and price alerts for Vitrolife AB are inside MarketPulse — currently in private beta.

Company data by Eulerpool. Logos provided by Elbstream. Reported figures, not investment advice.

Vitrolife AB (VITR.ST) — company profile and financials · MarketPulse